Geron Corp. March 15, 2024 - by Joey Ramson Shares of $GERN are surging today and up nearly 100% after an advisory panel to the FDA voted in favor of the company’s blood-disorder drug Imetelstat, and said its benefits outweigh the risks. Share this article:
